Jiayin Yao

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Reply.

Reply.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 06, 2026

Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.

Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.

Journal: Frontiers in immunology

Published: June 10, 2026

Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial.

Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 19, 2025

Comparative risk of Clostridioides difficile infection in patients with Crohn's disease receiving ustekinumab versus anti-TNF therapy: a retrospective cohort study.

Comparative risk of Clostridioides difficile infection in patients with Crohn's disease receiving ustekinumab versus anti-TNF therapy: a retrospective cohort study.

Journal: Therapeutic advances in gastroenterology

Published: November 14, 2025

CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease.

CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease.

Journal: Abdominal radiology (New York)

Published: August 23, 2025

Age-Stratified Efficacy of Upadacitinib in Refractory Pediatric Crohn's Disease and Geriatric Ulcerative Colitis: An Asian Cohort Study.

Age-Stratified Efficacy of Upadacitinib in Refractory Pediatric Crohn's Disease and Geriatric Ulcerative Colitis: An Asian Cohort Study.

Journal: Journal of inflammation research

Published: May 10, 2025

Editorial: The role of gut microbiota-gut-brain axis in inflammatory bowel disease.

Editorial: The role of gut microbiota-gut-brain axis in inflammatory bowel disease.

Journal: Frontiers in medicine

Published: February 01, 2025

Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis.

Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis.

Journal: International journal of biological macromolecules

Published: January 06, 2025

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study.

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study.

Journal: Biomedicines

Published: December 20, 2024

Prediction of endoscopic restenosis after endoscopic balloon dilation in patients with Crohn's disease: a machine learning approach.

Prediction of endoscopic restenosis after endoscopic balloon dilation in patients with Crohn's disease: a machine learning approach.

Journal: Surgical endoscopy

Published: December 16, 2024

Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn's Disease.

Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn's Disease.

Journal: Journal of inflammation research

Published: July 17, 2024

Associations of genetically predicted iron status with 24 gastrointestinal diseases and gut microbiota: a Mendelian randomization study.

Associations of genetically predicted iron status with 24 gastrointestinal diseases and gut microbiota: a Mendelian randomization study.

Journal: Frontiers in genetics

Published: March 24, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026